Medicare Part B reimburses doctors for administering prescription medication to a patient in a doctor's office or hospital outpatient facility for the cost of the drug plus an additional 6%.
Because the more expensive the medication the more the doctor is paid, the doctors have an obvious incentive to use expensive medications even when a cheaper alternative is just as effective. This hurts patients who are required to make co-payments.
To change this incentive and lower costs Bankrate reports that Medicare is proposing new rules in "Medicare prods docs to prescribe cheaper drugs."
The proposed changes include:
- Lowering the amount doctors are reimbursed from the current 6% to 2.5% to give less incentive to use expensive medications.
- Eliminate or reduce patient cost-sharing so patients are not financially hurt when doctors prescribe more expensive medications.
- Introduce a new payment structure that depends on the effectiveness of a medication. The more effective a medication the more doctors would be reimbursed for using it. In turn, this would give them a financial incentive to administer cheaper, better medications.
It is important to note that these proposed rule changes are not yet in effect. They also do not effect Medicare Part D prescriptions that are not administered by doctors.
Public comments on the proposal are being accepted through May 9, 2016.
Reference: Bankrate (March 15, 2016) "Medicare prods docs to prescribe cheaper drugs."